Lei Zhang

professor
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin 300020, China
Tianjin, Tianjin, China (People's Republic)

Presentation(s):

• OC 05.2 - Metabolomics profile and machine learning prediction of treatment responses in immune thrombocytopenia: a prospective cohort study

  Saturday, June 22, 2024
  13:15 – 13:30 ICT

• OC 05.5 - Increased levels of glycolysis in CD4+ T cells of patients with Immune Thrombocytopenia

  Saturday, June 22, 2024
  14:00 – 14:15 ICT

• OC 13.1 - Long-Term Impact of Splenectomy on Immune Status in Patients with ITP

  Sunday, June 23, 2024
  09:30 – 09:45 ICT

• OC 13.2 - Proteomics Landscape and Machine Learning Prediction of Long-term Response to Splenectomy in Primary Immune Thrombocytopenia

  Sunday, June 23, 2024
  09:45 – 10:00 ICT

• PB0265 - Reduced doses of emicizumab achieve good efficacy: results from a national-wide multicenter real-world study in China

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 30.4 - Sustained efficacy of gene transfer with BBM-H901 in Chinese Hemophilia B patients: results of long term follow up

  Monday, June 24, 2024
  10:15 – 10:30 ICT

• PB0562 - Combined Factor V and Factor VIII deficiency in China: Phenotype and current status of management

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0571 - Congenital factor Ⅴ deficiency in China

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0691 - Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: identification of a novel pathogenic mutation

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0676 - Spleen Microbiota Dysbiosis Play a Role in Response to Splenectomy in Patients with Primary Immune Thrombocytopenia: a Prospective Cohort Study

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB1314 - Identification of novel risk variants of inflammatory factors related to myeloproliferative neoplasm: a bidirectional Mendelian randomization study

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1313 - Platelet Multi-omics Analysis Confirms Hyperglycemia as a Risk Factor for Thrombosis in JAK2V617F-positive Essential Thrombocythemia

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT